[ad_1]
TEWKSBURY, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — Cambridge Isotope Laboratories, Inc., the world’s main producer of steady isotopes and steady isotope-labeled compounds, is happy to announce the addition of John Bakke as Vice President of Finance. John experiences on to the CEO, Cliff Caldwell.
John is a pacesetter who brings over 30 years of private and non-private firm expertise in a variety of finance and enterprise features inside numerous industries, having held a number of senior-level positions from company VP, common supervisor, controller, and senior monetary analyst for each nationwide and world companies.
Previous to becoming a member of CIL, John has most not too long ago been working as a director for Danforth Advisors aiding biotech and pharmaceutical purchasers to handle and develop their enterprise. Earlier than Danforth, John spent over 22 years with Charles River Laboratories working in numerous finance roles, together with a few years as a enterprise unit controller adopted by 11 years managing Charles River’s Avian Vaccine Service enterprise.
“CIL has skilled large progress the previous few years. We’re an organization stuffed with skilled staff dedicated to supporting the scientific discovery and commercialization of isotopes throughout a broad vary of extraordinarily high-value functions,” mentioned Cliff Caldwell, CEO. “I’m excited to have John be a part of our senior management group. John’s expertise, monetary experience, and management qualities can be a invaluable addition to Cambridge Isotopes supporting that progress.”
“I’m very happy and excited to be a member of the CIL group,” provides John, “and I’m wanting ahead to serving to CIL obtain its progress targets for the longer term.”
About Cambridge Isotope Laboratories, Inc.
CIL is the world’s largest producer and world provider of steady isotopes and steady isotope-labeled compounds utilized in analysis, environmental, neonatal, pharmaceutical, medical diagnostic, OLED, and industrial markets. CIL is an working enterprise owned by Otsuka Prescribed drugs. The CIL enterprise consists of two amenities within the Boston, MA, space; a big isotope-enrichment manufacturing plant in Xenia, OH; CIL China; CIL Canada; ABX in Dresden, Germany; and Eurisotop in Saclay, France.
For extra info on CIL, go to isotope.com.
Contact Info:
Crissy Krisko
Telephone: 1.978.749.8000
Fax: 1.978.749.2768
www.isotope.com
Associated Photographs
Picture 1: John Bakke, VP of Finance
This content material was issued by way of the press launch distribution service at Newswire.com.
[ad_2]
Supply hyperlink